Inhibitors of hepatitis C virus NS3·4A protease 1. Non-Charged tetrapeptide variants

This publication has 19 references indexed in Scilit:

• Recent developments in the discovery of hepatitis C virus serine protease inhibitors – towards a new class of antiviral agents?
  Expert Opinion on Investigational Drugs, 2003
• Capped dipeptide α-Ketoacid inhibitors of the HCV NS3 protease
  Bioorganic & Medicinal Chemistry Letters, 2002
• Future therapy of hepatitis C
  Hepatology, 2002
• Hepatitis C therapeutics: current status and emerging strategies
  Nature Reviews Drug Discovery, 2002
• Tetrapeptides as potent protease inhibitors of hepatitis C virus full-Length NS3 (Protease-Helicase/NTPase)
  Bioorganic & Medicinal Chemistry, 2002
• 5 Inhibitors of Hepatitis C Virus NS3•4A Protease: An Overdue Line of Therapy
  Progress in Medicinal Chemistry, 2002
• Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2000
• α-Ketoamides, α-ketoesters and α-diketones as HCV NS3 protease inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2000
• Potent Peptide Inhibitors of Human Hepatitis C Virus NS3 Protease Are Obtained by Optimizing the Cleavage Products
  Biochemistry, 1998
• Product Inhibition of the Hepatitis C Virus NS3 Protease
  Biochemistry, 1998